Industry
Analyzing SABS’s price-to-book ratio for the last quarter
In the current trading session, SAB Biotherapeutics Inc’s (SABS) stock is trading at the price of $2.58, a gain of 6.61% over last night’s close.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.